Chris Ponting did some commentary as well on Bluesky:
The 2026 PRIME symposium kicks off with reflections from Kelly McLellan on the importance of Patient and Public Involvement in ME/CFS research. #Prime26 #pwME #mecfs
Now up: Hannah Ollila (Helsinki) launching the new international Genetics Epidemiology of ME/CFS (GEM) consortium. Contrasting the genetics & infection trigger of narcolepsy vs #MEcfs. Narcolepsy: HLA-DQB1*06:02 carriers & autoimmunity. Talking about the importance of whole genome sequencing.
Now launches the new consortium. Its point is to identify #MEcfs pathomechanisms, susceptibility and recovery. 60,542 cases and 2.8 million controls. Well powered! Case definition: diverse info, not all optimal.
New results. Eleven associations! Focuses on EXD3 Val540Met. (NB: unpublished results that need replication.)
Genetic overlap with neuronal, immune, endocrine and sleep traits.
EXD3 missense variant in exonuclease catalytic cleft. Immune function?
Two signals in TMEM106B & VWDE locus. Associations affect gene regulation not protein sequence. Genome wide: the pituitary tissue is the most enriched in gene expression.
Is #MEcfs genetics similar to other diseases? Yes! Long Covid and fibromyalgia have strong genetic correlations w MEcfs.